STOCK TITAN

Royalty Pharma: Sandy Lamm LLC sells 25,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Royalty Pharma plc (RPRX) EVP, Research & Investments Marshall Urist reported that Sandy Lamm LLC sold 25,000 Class A Ordinary Shares on November 16, 2026, in two transactions under a Rule 10b5-1 plan adopted August 7, 2026. The weighted-average prices were $69.4701 for 23,592 shares and $69.9941 for 1,408 shares; the disclosed transaction ranges were $68.93–$69.92 and $69.92–$70.00 per share, respectively.

The statement also lists 19,020 shares held indirectly by an IRA and 5,341 shares held directly. It says Marshall Urist and family vehicles hold limited partnership interests exchangeable into 2,294,120 Class A Ordinary Shares, and Class E Ordinary Shares exchangeable into 1,356,528 Class A Ordinary Shares; the Class E shares are subject to vesting conditions.

Insider Urist Marshall
Role EVP, Research & Investments
Sold 25,000 shs ($1.74M)
Type Security Shares Price Value
Sale Class A Ordinary Shares F1, F2 23,592 $69.4701 $1.64M
Sale Class A Ordinary Shares F1, F3 1,408 $69.9941 $99K
Holding Class A Ordinary Shares -- -- --
Holding Class A Ordinary Shares -- -- --
Holdings After Transaction: Class A Ordinary Shares — 125,000 shares (Indirect, By Sandy Lamm LLC); Class A Ordinary Shares — 19,020 shares (Indirect, By IRA); Class A Ordinary Shares — 5,341 shares (Direct)
Footnotes (3)
  1. F1. All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 7, 2026.
  2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.93 to $69.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.92 to $70.00 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Class A Ordinary Shares sold 25,000 shares Sandy Lamm LLC transactions on November 16, 2026
Shares sold in first transaction 23,592 shares November 16, 2026; weighted-average sale price was $69.4701 per share
Weighted-average sale price $69.4701 per share Transaction involving 23,592 shares; disclosed transaction range was $68.93 to $69.92 per share
Shares sold in second transaction 1,408 shares November 16, 2026; weighted-average sale price was $69.9941 per share
Weighted-average sale price $69.9941 per share Transaction involving 1,408 shares; disclosed transaction range was $69.92 to $70.00 per share
Indirect shares held by IRA 19,020 shares Class A Ordinary Shares listed on November 16, 2026
Direct shares held 5,341 shares Class A Ordinary Shares listed on November 16, 2026
Rule 10b5-1 plan regulatory
"the sales made under a plan adopted August 7, 2026"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"the reported price for each sale transaction"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
limited partnership interests technical
"interests exchangeable into Class A Ordinary Shares"
An ownership stake in a limited partnership gives an investor the role of a limited partner who provides capital but does not run day-to-day operations; a separate general partner manages the business. It matters because limited partners share profits, losses, and tax benefits but generally cannot lose more than they invested and have little control or liquidity—think of it like quietly funding a small business while someone else manages it, with potential return and risk tied to the venture’s performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares did Sandy Lamm LLC sell, and at what prices?

Sandy Lamm LLC sold 25,000 Class A Ordinary Shares on November 16, 2026, in two reported transactions under a Rule 10b5-1 plan adopted August 7, 2026. The weighted-average prices were $69.4701 for 23,592 shares and $69.9941 for 1,408 shares, with disclosed transaction ranges of $68.93 to $69.92 and $69.92 to $70.00 per share, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Urist Marshall

(Last)(First)(Middle)
C/O ROYALTY PHARMA PLC
110 EAST 59TH STREET

(Street)
NEW YORK NEW YORK 10022

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Royalty Pharma plc [ RPRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Research & Investments
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Ordinary Shares11/16/2026S(1)23,592D$69.4701(2)126,408IBy Sandy Lamm LLC
Class A Ordinary Shares11/16/2026S(1)1,408D$69.9941(3)125,000IBy Sandy Lamm LLC
Class A Ordinary Shares19,020IBy IRA
Class A Ordinary Shares5,341D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 7, 2026.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.93 to $69.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.92 to $70.00 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 2,294,120 Class A Ordinary Shares and Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 1,356,528 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.
/s/ Sean Weisberg, as Attorney-in-Fact, for Marshall Urist11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading